TTD Drug ID: DNC005981

Drug Information
Name	L-869298
Indication	Not Available			Experimental
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
InChI	1S/C23H18F8N2O4S/c24-20(25)37-16-6-3-13(9-17(16)36-14-4-5-14)15(8 -12-2-1-7-33(35)11-12)18-10-32-19(38-18)21(34,22(26,27)28)23(29,3 0)31/h1-3,6-7,9-11,14-15,20,34H,4-5,8H2/t15-/m0/s1
InChIKey	YDLQPURWTSDWCC-HNNXBMFYSA-N
Canonical SMILES	C1CC1OC2=C(C=CC(=C2)C(CC3=C[N+](=CC=C3)[O-])C4=CN=C(S4)C(C(F)(F)F)(C(F) (F)F)O)OC(F)F
Isomeric SMILES	C1CC1OC2=C(C=CC(=C2)[C@H](CC3=C[N+](=CC=C3)[O-])C4=CN=C(S4)C(C(F)(F)F)(C (F)(F)F)O)OC(F)F
Target	Phosphodiesterase 4A			Inhibitor	[1]
	Phosphodiesterase 4B			Inhibitor	[1]
	Phosphodiesterase 4D			Inhibitor	[1]
Ref 1	J Med Chem. 2006 Mar 23;49(6):1867-73.Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.